- Home
- Lobbying firms
- W Strategies, LLC
W Strategies, LLC
Lobbying firm · Jul 2025 – Sep 2026
W Strategies, LLC earned $3.7M lobbying for 24 clients (Jul 2025 – Sep 2026). Biggest clients: Astrazeneca Pharmaceuticals LP, Gilead Sciences, Inc., Incyte Corporation.
- Lobbying income
- $3.7M
- Clients
- 24
Clients
- Astrazeneca Pharmaceuticals LP$320K
- Gilead Sciences, Inc.$240K
- Incyte Corporation$240K
- Juul Labs, Inc.$240K
- Pharmaceutical Research And Manufacturers Of America$240K
- Abbott Laboratories$200K
- Abbvie Inc.$200K
- Merck & Co. Inc.$200K
- Otsuka America Pharmaceutical, Inc.$200K
- Phlow Corporation$200K
- Sanofi US Services Inc$200K
- California Life Sciences$160K
- Glaxosmithkline LLC$160K
- Medtronic, Inc.$160K
- Paperbirch Strategies On Behalf Of AP3 Biomedical$140K
- Delfi Diagnostics$120K
- United Services Automobile Association$120K
- Ipsen Biopharmaceuticals, Inc.$80K
- Bristol-Myers Squibb Company$80K
- Elevatebio$70K
- Exelixis, Inc.$60K
- Supernus Pharmaceuticals Fka Sage Therapeutics$50K
- Dyne Therapeutics, Inc.$40K
- Alveo Technologies$0
More
From Lobbying Disclosure Act reports.
Cite or embed this page
Capitol Receipts, “W Strategies, LLC: Lobbying Firm Clients & Income,” https://www.capitolreceipts.com/lobbying-firm/fwstrategiesllc/w-strategies-llc (accessed 2026-10-17).